A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson’s disease ; volume:19 ; number:1 ; day:22 ; month:5 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of neuroinflammation ; 19, Heft 1 (22.5.2022), 1-21, 12.2022
- Urheber
-
Lu, Jia
Wang, Chenfei
Cheng, Xin
Wang, Ruizhi
Yan, Xuehan
He, Pengju
Chen, Hongzhuan
Yu, Zhihua
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-022-02484-0
- URN
-
urn:nbn:de:101:1-2022072600321364107500
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lu, Jia
- Wang, Chenfei
- Cheng, Xin
- Wang, Ruizhi
- Yan, Xuehan
- He, Pengju
- Chen, Hongzhuan
- Yu, Zhihua
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Models of α-synuclein aggregation in Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Models of α-synuclein aggregation in Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
Models of α-synuclein aggregation in Parkinson’s disease
Microglial activation in Parkinson’s disease using [18F]-FEPPA
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity